Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma

Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDA) is an extremely lethal malignancy arising from the pancreas. The treatment of PDA is complicated by ineffective treatments and a lack of biomarkers predictive of treatment success. We have designed a patient-derived organoid (PDO) based high-throughput drug scr...

Full description

Bibliographic Details
Main Authors: Andrew Armstrong, Muhammad R. Haque, Sina Mirbagheri, Usman Barlass, Douglas Z. Gilbert, Jaimin Amin, Ajaypal Singh, Ankur Naqib, Faraz Bishehsari
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Biomedicines
Subjects:
pancreatic ductal adenocarcinoma
patient-derived organoid
drug screening
Online Access:https://www.mdpi.com/2227-9059/9/7/705

Internet

https://www.mdpi.com/2227-9059/9/7/705

Similar Items